Home › Funds › PRIMECAP MANAGEMENT CO/CA/ › BIIB

PRIMECAP MANAGEMENT CO/CA/ position in BIIB

BIOGEN INC · Health Care

PRIMECAP MANAGEMENT CO/CA/ reported holding 15,197,022 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$3.43B, representing 2.13% of its reported portfolio and ranking #8 among its reported holdings. PRIMECAP MANAGEMENT CO/CA/ has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.20M sh
Reported value held$3.43B
Portfolio Weight2.13%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PRIMECAP MANAGEMENT CO/CA/'s BIIB position evolved

PRIMECAP MANAGEMENT CO/CA/ first disclosed a stake in BIIB in Q3 2023 at 16,012,566 shares (US$4.12B). The position peaked in Q4 2023 at 16,264,481 shares, worth US$4.21B. Across 13 filings, PRIMECAP MANAGEMENT CO/CA/ increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 15,197,022 shares valued at US$3.43B.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.01M $4.12B New
Q4 2023 16.26M $4.21B Add
Q1 2024 16.22M $3.50B Hold
Q2 2024 16.34M $3.79B Add
Q3 2024 16.32M $3.16B Hold
Q4 2024 16.05M $2.45B Reduce
Q1 2025 15.94M $2.18B Reduce
Q2 2025 15.80M $1.98B Reduce
Q3 2025 14.95M $2.09B Reduce
Q4 2025 14.76M $2.60B Reduce
Q1 2026 14.76M $2.71B Hold
Q2 2026 15.15M $3.27B Add
Q3 2026 15.20M $3.43B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 19 other funds we track also report a position in BIIB. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

No other tracked fund reports a position in BIIB.

All BIIB fund holders →

FAQ

How long has PRIMECAP MANAGEMENT CO/CA/ held BIIB?

PRIMECAP MANAGEMENT CO/CA/ has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PRIMECAP MANAGEMENT CO/CA/'s current position in BIIB?

As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 15.20M shares of BIIB (BIOGEN INC), valued at $3.43B, representing 2.13% of its reported portfolio and ranking #8.

Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling BIIB?

In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ held unchanged its position in BIIB. The position peaked in Q4 2023 at 16.26M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.